SELECTION OF AN ORALLY-ACTIVE GLYCOPROTEIN-IIB/IIIA RECEPTOR ANTAGONIST FOR CLINICAL-TRIALS

J ZABLOCKI,N NICHOLSON, B TAITE, S PANZERKNODLE,A SALYERS,N HAAS, J SZALONY, L FEIGEN, M HERIN, P JACQMIN, M LESNE,P BOVY,FS TJOENG

THROMBOSIS AND HAEMOSTASIS（1993）

Cited 0|Views3

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined